One potential underlying mechanism involves low adiponectin levels,28 which relate inversely to body fat in men but, to a stronger degree, with metabolic and hormonal factors in women,29 potentially intensifying the adverse impact of obesity on multiple myeloma risk in women. Here, ADIPOQ is linked to obesity due to melanocortin 4 receptor deficiency.